title: Primary cutaneous anaplastic large-cell lymphoma.
abstract: Since the recognition of the anaplastic large-cell lymphomas in the 1980s, much has been learned about the diagnosis, clinical presentation, and treatment of these malignant conditions. The systemic and primary cutaneous types of anaplastic large cell lymphomas have been differentiated on clinical and immunophenotypical findings, but further research is required to elucidate their exact etiologies and pathogeneses. Primary cutaneous anaplastic large-cell lymphoma has a 95% disease-specific 5-year survival, owing partly to the relatively benign course of the disease and partly to the variety of effective treatments that are available. As with many other oncological diseases, new drugs are continually being tested and developed, with immunotherapy and biological response modifiers showing promise.
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, George Washington University School of Medicine, Washington, DC.
authors.forename: Edward
authors.initials: E
authors.lastname: Perry
authors.forename: Jay
authors.initials: J
authors.lastname: Karajgikar
authors.forename: Imad A
authors.initials: IA
authors.lastname: Tabbara
mesh_terms: D006801:Humans; D054446:Lymphoma, Primary Cutaneous Anaplastic Large Cell / Q000175:diagnosis / Q000628:therapy*; D011379:Prognosis; D012878:Skin Neoplasms / Q000175:diagnosis / Q000628:therapy*